|
Loading...
| ||||||||||||||
Recent Publications by AstraZeneca: |  | |
| Molybdenum-Mediated Carbonylation of Aryl Halides with Nucleophiles Using Microwave Irradiation.
A new, efficient, and practical molybdenum-mediated carbonylation of aryl... | Department of Chemistry, AstraZeneca R&D Charnwood, Bakewell Road, | Org Lett. 2010 Aug 26.
DOI Direct Link |
| Introduction to the special issue on Alzheimer's disease.
A new, efficient, and practical molybdenum-mediated carbonylation of aryl... | EVP, Innovative Medicines AstraZeneca, Room 11F63, Mereside, Alderley | Neuropharmacology. 2010 Oct-Nov;59(4-5):219-20.
DOI Direct Link |
| Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1.
Initial high throughput screening efforts identified highly potent and... | CNS Discovery Research, AstraZeneca Pharmaceuticals, 1800 Concord Pike, | Bioorg Med Chem Lett. 2010 Jul 30.
DOI Direct Link |
| A commentary on the process of peer review and pathology data locking.
Initial high throughput screening efforts identified highly potent and... | AstraZeneca, UK. | Exp Toxicol Pathol. 2010 Aug 18.
DOI Direct Link |
| Observed peptide pI and retention time shifts as a result of post-translational modifications in multidimensional separations using narrow-range IPG-IEF.
Modified peptides constitute a sub-population among the tryptic peptides... | Department of Safety Assessment, Molecular Toxicology, AstraZeneca R&D, | Amino Acids. 2010 Aug 20.
DOI Direct Link |
